vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and WIDEPOINT CORP (WYY). Click either name above to swap in a different company.
WIDEPOINT CORP is the larger business by last-quarter revenue ($42.3M vs $21.2M, roughly 2.0× Autolus Therapeutics plc). WIDEPOINT CORP runs the higher net margin — -2.0% vs -373.3%, a 371.3% gap on every dollar of revenue. WIDEPOINT CORP produced more free cash flow last quarter ($-270.0K vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
WidePoint Corporation is an American company based in Fairfax, Virginia that provides technology-based products and services to the government sector and commercial markets in the United States. The company holds a patent for a digital parsing tool that allows users to access accounts through a secure repository gateway, established using asymmetric authentication employed as public key infrastructure (PKI). WidePoint provides smart card identity verification, wireless expense management, pen...
AUTL vs WYY — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $42.3M |
| Net Profit | $-79.1M | $-849.4K |
| Gross Margin | — | 13.8% |
| Operating Margin | -337.9% | -1.9% |
| Net Margin | -373.3% | -2.0% |
| Revenue YoY | — | 12.3% |
| Net Profit YoY | 3.6% | -138.3% |
| EPS (diluted) | $-0.30 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $42.3M | ||
| Q3 25 | $21.2M | $36.1M | ||
| Q2 25 | $20.9M | $37.9M | ||
| Q1 25 | $9.0M | $34.2M | ||
| Q4 24 | — | $37.7M | ||
| Q3 24 | $0 | $34.6M | ||
| Q2 24 | $0 | $36.0M | ||
| Q1 24 | $10.1M | $34.2M |
| Q4 25 | — | $-849.4K | ||
| Q3 25 | $-79.1M | $-559.2K | ||
| Q2 25 | $-47.9M | $-618.5K | ||
| Q1 25 | $-70.2M | $-724.1K | ||
| Q4 24 | — | $-356.4K | ||
| Q3 24 | $-82.1M | $-425.2K | ||
| Q2 24 | $-58.3M | $-499.6K | ||
| Q1 24 | $-52.7M | $-653.1K |
| Q4 25 | — | 13.8% | ||
| Q3 25 | — | 14.6% | ||
| Q2 25 | — | 13.5% | ||
| Q1 25 | — | 14.0% | ||
| Q4 24 | — | 12.6% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 13.6% | ||
| Q1 24 | — | 13.6% |
| Q4 25 | — | -1.9% | ||
| Q3 25 | -337.9% | -1.3% | ||
| Q2 25 | -292.6% | -1.9% | ||
| Q1 25 | -726.3% | -2.4% | ||
| Q4 24 | — | -0.8% | ||
| Q3 24 | — | -1.3% | ||
| Q2 24 | — | -1.3% | ||
| Q1 24 | -384.1% | -1.9% |
| Q4 25 | — | -2.0% | ||
| Q3 25 | -373.3% | -1.5% | ||
| Q2 25 | -229.0% | -1.6% | ||
| Q1 25 | -781.1% | -2.1% | ||
| Q4 24 | — | -0.9% | ||
| Q3 24 | — | -1.2% | ||
| Q2 24 | — | -1.4% | ||
| Q1 24 | -522.1% | -1.9% |
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $-0.30 | $-0.06 | ||
| Q2 25 | $-0.18 | $-0.06 | ||
| Q1 25 | $-0.26 | $-0.08 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $-0.31 | $-0.04 | ||
| Q2 24 | $-0.22 | $-0.05 | ||
| Q1 24 | $-0.24 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $9.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $11.5M |
| Total Assets | $661.9M | $79.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $9.8M | ||
| Q3 25 | $86.1M | $12.1M | ||
| Q2 25 | $123.8M | $6.8M | ||
| Q1 25 | $95.8M | $3.7M | ||
| Q4 24 | — | $6.8M | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $11.5M | ||
| Q3 25 | $265.5M | $12.2M | ||
| Q2 25 | $346.5M | $12.6M | ||
| Q1 25 | $371.1M | $13.0M | ||
| Q4 24 | — | $13.6M | ||
| Q3 24 | $477.0M | $13.8M | ||
| Q2 24 | $527.8M | $14.0M | ||
| Q1 24 | $582.0M | $14.2M |
| Q4 25 | — | $79.8M | ||
| Q3 25 | $661.9M | $70.6M | ||
| Q2 25 | $721.0M | $76.6M | ||
| Q1 25 | $746.3M | $71.4M | ||
| Q4 24 | — | $71.6M | ||
| Q3 24 | $827.5M | $56.9M | ||
| Q2 24 | $853.6M | $58.6M | ||
| Q1 24 | $901.4M | $54.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $-173.5K |
| Free Cash FlowOCF − Capex | $-72.3M | $-270.0K |
| FCF MarginFCF / Revenue | -341.2% | -0.6% |
| Capex IntensityCapex / Revenue | 20.8% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-173.5K | ||
| Q3 25 | $-67.9M | $5.9M | ||
| Q2 25 | $-72.8M | $3.2M | ||
| Q1 25 | $-75.6M | $-3.2M | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | $-76.7M | $1.9M | ||
| Q2 24 | $-51.1M | $-1.1M | ||
| Q1 24 | $-40.5M | $-1.6M |
| Q4 25 | — | $-270.0K | ||
| Q3 25 | $-72.3M | $5.9M | ||
| Q2 25 | $-80.1M | $3.1M | ||
| Q1 25 | $-83.8M | $-3.3M | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | $-86.3M | $1.8M | ||
| Q2 24 | $-51.9M | $-1.1M | ||
| Q1 24 | $-41.0M | $-1.6M |
| Q4 25 | — | -0.6% | ||
| Q3 25 | -341.2% | 16.4% | ||
| Q2 25 | -382.6% | 8.1% | ||
| Q1 25 | -933.1% | -9.5% | ||
| Q4 24 | — | 6.4% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | -3.0% | ||
| Q1 24 | -406.8% | -4.6% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 20.8% | 0.1% | ||
| Q2 25 | 34.8% | 0.2% | ||
| Q1 25 | 91.8% | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | 5.3% | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AUTL
Segment breakdown not available.
WYY
| Carrier Services | $26.8M | 63% |
| Managed Services | $15.5M | 37% |
